US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...
By Josh Ye and David Kirton HONG KONG (Reuters) -Alibaba Group Holdings and Huawei Technologies...
By Andrea Shalal and Yew Lun Tian BEIJING (Reuters) -U.S. Treasury Secretary Janet Yellen on...
WASHINGTON (Reuters) – The Pentagon holds a strategic U.S. stockpile for germanium but currently has...
A look at the day ahead in U.S. and global markets from Mike Dolan World...
SHANGHAI/HONG KONG (Reuters) – Chinese investors are rushing offshore to make dollar deposits and buy...
By Brenda Goh, Supantha Mukherjee and Kanishka Singh SHANGHAI/STOCKHOLM/WASHINGTON (Reuters) -China’s decision this week to...
By Sinéad Carew and Tom Wilson NEW YORK/LONDON (Reuters) – MSCI’s global equities index lost...
By Foo Yun Chee BRUSSELS (Reuters) -Seven companies including Amazon, Apple, Google, Facebook-owner Meta and...
By Amy Lv and Brenda Goh BEIJING/SHANGHAI (Reuters) -Companies caught out by China’s decision to...